Illumina, Inc.
Large Cap · Healthcare · Diagnostics & Research
$199.44+$11.15 (+5.92%)
Illumina, Inc.
Large Cap · Healthcare · Diagnostics & Research
$199.44+$11.15 (+5.92%)
Stock analysis
Get the AI take on ILMN
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$88.00
High$196.66
Today $199.44
RSI (14)
47.9Neutral
03070100
Overall score
59/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$113
Current price
$199.44
Median target
$211
Highest
$230
LowHigh
Operating Record
Revenue
What's working
- ROIC: Money put back into the business keeps coming back out as profit, a hallmark of a durable moat.
- ROE: Shareholder capital is compounding at a rate worth paying attention to.
What to watch
- Debt exceeds cash by $1.4B, increasing balance-sheet pressure, a warning sign.
- Forward P/E: The price already assumes strong earnings growth that still has to show up.
What the market charges
Forward P/E
Needs attention · 62% above avg
33.46x
Price / sales
Reasonable · Priced reasonably against its revenue
6.41x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
30.96x
EV / EBITDA
Rich · Operating earnings don't yet support this price
26.13x
How efficiently it compounds
ROIC
Strong · Comfortably clears the bar for efficient capital use
17.4%
ROE
Favorable · 33.8% - strong capital efficiency
32.3%
Debt / equity
Middle ground · Mixed
0.89x
Current ratio
Strong · Comfortable room to cover bills due within a year
1.80x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $28.82B | 35.6 | +4.9% | 59 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |